Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous lymphomas.

Reinhard Dummer1, Rudolf Stadler, Wolfram Sterry

  • 1Department of Dermatology, University of Zurich, Switzerland. reinhard.dummer@usz.ch

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|July 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving impact of long-term survival results on metastatic melanoma treatment.

Journal for immunotherapy of cancer·2020
Same author

Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i.

Nature medicine·2020
Same author

Retrospective Analysis of Treatment and Complications of Immune Checkpoint Inhibitor-Associated Colitis: Histological Ulcerations as Potential Predictor for a Steroid-Refractory Disease Course.

Inflammatory intestinal diseases·2020
Same author

Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'.

European journal of cancer (Oxford, England : 1990)·2020
Same author

Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma.

Oncotarget·2020
Same author

Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma: A Review.

JAMA oncology·2020
Same journal

The different face of skin-rash induced by brentuximab vedotin.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Repositioning Non-Ablative Fractional Lasers - Molecular and Histological Insights from a scoping review.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Infusion-site reactions to foslevodopa/foscarbidopa in Parkinson's disease.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Tranexamic Acid-Soaked Intranasal Packing for Postoperative Bleeding After Nasal Interpolation Flap Repair.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Monoclonal gammopathy of dermatological significance: non-amyloid paraprotein deposits with light and heavy chains.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Papular epidermal nevus with "skyline" basal cell layer: Clinical clues from a three-member family.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
See all related articles

Cutaneous lymphomas are rare skin diseases requiring differentiation from other conditions. While a cure isn't possible, managing these lymphomas involves controlling the disease and alleviating symptoms with new drug developments.

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Cutaneous lymphomas are rare skin diseases.
  • They require differentiation from secondary skin infiltrates of primary nodal lymphomas.
  • Primary cutaneous lymphomas, including B-cell, T-cell lymphomas, and hematodermic neoplasms, typically have a favorable prognosis and a chronic course.

Purpose of the Study:

  • To provide an overview of cutaneous lymphomas.
  • To highlight the importance of differentiating primary cutaneous lymphomas from secondary infiltrates.
  • To discuss current treatment strategies and recent advancements in drug development for managing these conditions.

Main Methods:

  • Literature review on cutaneous lymphomas.
  • Classification of primary cutaneous lymphomas.

Related Experiment Videos

  • Discussion of diagnostic challenges and therapeutic approaches.

    • Main Results:

    • Primary cutaneous lymphomas are distinct from nodal lymphomas.
    • These lymphomas generally follow a chronic course with a favorable prognosis.
    • Treatment is stage-dependent, focusing on disease control and symptom management.

    Conclusions:

    • Accurate diagnosis and differentiation are crucial for effective management.
    • Complete cure is not achievable; therefore, long-term disease control and symptom alleviation are primary goals.
    • Recent advancements in pharmacotherapy offer improved options for treating cutaneous lymphomas.